Cargando…
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
COVID-19 shares the feature of autoantibody production with systemic autoimmune diseases. In order to understand the role of these immune globulins in the pathogenesis of the disease, it is important to explore the autoantibody spectra. Here we show, by a cross-sectional study of 246 individuals, th...
Ejemplares similares
-
Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients
por: Lavi, Yael, et al.
Publicado: (2023) -
Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach
por: Fonseca, Dennyson Leandro M., et al.
Publicado: (2023) -
Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity
por: Sotzny, Franziska, et al.
Publicado: (2022) -
Catastrophic Embolism Following Cosmetic Injection of Autologous Fat: Are Silicone-Treated Syringes the Only Suspects on the Crime Scene?
por: Vojdani, Aristo, et al.
Publicado: (2022) -
Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases
por: Graßhoff, Hanna, et al.
Publicado: (2021)